Serina Therapeutics Inc. Revenue 2017–2025
Serina Therapeutics Inc. annual/quarterly revenue history and growth rate from 2017 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Serina Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Serina Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 144000, a 56.52% increase year-over-year.
- Serina Therapeutics Inc. annual revenue for 2025 was 130000, a 132.14% increase from 2024.
- Serina Therapeutics Inc. annual revenue for 2024 was 56000, a 98.22% decrease from 2023.
- Serina Therapeutics Inc. annual revenue for 2023 was 3.2 M, a 9173.53% increase from 2022.
- Serina Therapeutics Inc. annual revenue for 2022 was 34000.
Serina Therapeutics Inc. (SER) — Frequently Asked Questions
Serina Therapeutics Inc. (SER) is a publicly traded US company. It has a market capitalization of $18M. In fiscal 2025 it reported revenue of $130,000 and net income of -$19M. Explore SER's stock price, financial statements, earnings history, margins and key ratios below.
What is Serina Therapeutics Inc.'s market cap?
Serina Therapeutics Inc. (SER) has a market capitalization of $18M.
What is the SER stock price?
SER trades at $1.81 (+4.02% on the day).
How much revenue does Serina Therapeutics Inc. make?
Serina Therapeutics Inc. reported revenue of $130,000 in fiscal 2025.
Is SER profitable?
In fiscal 2025, Serina Therapeutics Inc. reported net income of -$19M.